바로가기  >

Abstract
Glioblastoma multiforme (GBM) is a malignant primary brain tumor with poor patient prognosis. Although the standard treatment of GBM is surgery followed by chemotherapy and radiotherapy, often a small portion of surviving tumor cells acquire therapeutic resistance and become more aggressive. Recently, altered kinase expression and activity have been shown to determine metabolic flux in tumor cells and metabolic reprogramming has emerged as a tumor progression regulatory mechanism. Here we investigated novel kinase-mediated metabolic alterations that lead to acquired GBM radioresistance and malignancy. We utilized transcriptomic analyses within a radioresistant GBM orthotopic xenograft mouse model that overexpresses the dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3). We find that within GBM cells, radiation exposure induces DYRK3 expression and DYRK3 regulates mammalian target of rapamycin complex 1 (mTORC1) activity through phosphorylation of proline-rich AKT1 substrate 1 (PRAS40). We also find that DYRK3 knockdown inhibits dynamin-related protein 1 (DRP1)-mediated mitochondrial fission, leading to increased oxidative phosphorylation (OXPHOS) and reduced glycolysis. Importantly, enforced DYRK3 downregulation following irradiation significantly impaired GBM cell migration and invasion. Collectively, we suggest DYRK3 suppression may be a novel strategy for preventing GBM malignancy through regulating mitochondrial metabolism.

Affiliations

Kyeongmin Kim  1 , Sungmin Lee  1 , Hyunkoo Kang  1 , Eunguk Shin  1 , Hae Yu Kim  2 , HyeSook Youn  3 , BuHyun Youn  1   4
1 Department of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
2 Department of Neurosurgery, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Korea.
3 Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea.
4 Department of Biological Sciences, Pusan National University, Busan 46241, Korea.